Who is eligible for GLP-1 weight-management treatment

Overview

Eligibility for GLP-1 treatment in the UK is governed by NICE (National Institute for Health and Care Excellence) and follows standards supported by the British Obesity & Metabolic Surgery Society (BOMSS).

NICE Eligibility Criteria

• BMI Threshold: Usually a BMI of 30 kg/m² or more, or 27 kg/m² or more with a weight-related comorbidity (e.g., hypertension, CKD, diabetes).
• Ethnicity Adjustment: Thresholds are lower (by 2.5 units) for individuals of South Asian, Chinese, Black African, or African-Caribbean family background.
• Comorbidities: CKD is considered a major weight-related condition that prioritises patients for treatment.

BOMSS Standards and Kidney Care

The British Obesity & Metabolic Surgery Society (BOMSS) highlights that weight management is a critical component of pre-transplant workup. Patients who are "too heavy" for the transplant list are a priority group at KidneyWeight Clinic.

CKD-Specific Considerations

In kidney disease, BMI is interpreted alongside:

• Fluid Status: "Dry weight" is used to avoid inflation by fluid retention.
• Muscle Mass: Monitoring for sarcopenia is essential, as CKD patients are at higher risk of muscle wasting.

Preparing for your appointment

My BMI is 29 — am I eligible?

If you have CKD or another weight-related condition, yes, according to NICE criteria.

I am on the transplant list — can I start?

Yes. Weight loss often improves the chances of a successful transplant and long-term graft survival.

References

• NICE CG189: Obesity identification, assessment and management
• BOMSS: Professional standards for weight management
• KDIGO 2024 Clinical Practice Guideline for CKD

This article is general patient information reviewed by a consultant nephrologist. It is not individual medical advice; treatment decisions are made at a face-to-face consultation.